Literature DB >> 34364815

Continuous glucose monitoring in cystic fibrosis-Benefits, limitations, and opportunities.

Christine L Chan1.   

Abstract

Entities:  

Year:  2021        PMID： 34364815     DOI： 10.1016/j.jcf.2021.07.016

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN： 1569-1993            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers.

Authors:  Laurence Weiss; Olivia Ronsin; Quitterie Reynaud; Michel Abely; Laurent Mely; Pierre-Régis Burgel; Jacques Beltrand; Laurence Kessler
Journal:  J Clin Transl Endocrinol       Date:  2022-04-04

2.  Oral Glucose Tolerance Test in Patients with Cystic Fibrosis Compared to the Overweight and Obese: A Different Approach in Understanding the Results.

Authors:  Mirela Mogoi; Liviu Laurentiu Pop; Mihaela Dediu; Ioana Mihaiela Ciuca
Journal:  Children (Basel)       Date:  2022-04-08

Review 3.  Comparison of continuous glucose monitoring to reference standard oral glucose tolerance test for the detection of dysglycemia in cystic Fibrosis: A systematic review.

Authors:  Shanal Kumar; Michael Pallin; Georgia Soldatos; Helena Teede
Journal:  J Clin Transl Endocrinol       Date:  2022-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.